World-class bioprocess modelling software developer unveils new customisable features for users. LONDON, 11 December 2019 – Biopharm Services, the bioprocess analysis software developer, today ...
A fully bioabsorbable drug-eluting stent (DES) shows improvements over its predecessor and competitive levels of target lesion failure (TLF) at 1 year, according to results published in the March 9, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback